Logo image of TYME

TYME TECHNOLOGIES INC (TYME) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TYME - US90238J1034 - Common Stock

0.3107 USD
+0.02 (+8.07%)
Last: 9/16/2022, 8:00:02 PM
0.2852 USD
-0.03 (-8.21%)
After Hours: 9/16/2022, 8:00:02 PM
Fundamental Rating

2

TYME gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. TYME scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TYME has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year TYME has reported negative net income.
TYME Yearly Net Income VS EBIT VS OCF VS FCFTYME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA -30.18%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TYME Yearly ROA, ROE, ROICTYME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300

1.3 Margins

  • TYME does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TYME Yearly Profit, Operating, Gross MarginsTYME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022

6

2. Health

2.1 Basic Checks

  • The number of shares outstanding for TYME remains at a similar level compared to 1 year ago.
  • TYME has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TYME Yearly Shares OutstandingTYME Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
TYME Yearly Total Debt VS Total AssetsTYME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 2.47 indicates that TYME is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • There is no outstanding debt for TYME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.47
ROIC/WACCN/A
WACCN/A
TYME Yearly LT Debt VS Equity VS FCFTYME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

  • TYME has a Current Ratio of 14.06. This indicates that TYME is financially healthy and has no problem in meeting its short term obligations.
  • TYME has a Quick Ratio of 14.06. This indicates that TYME is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 14.06
Quick Ratio 14.06
TYME Yearly Current Assets VS Current LiabilitesTYME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

0

3. Growth

3.1 Past

  • TYME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.61%, which is quite impressive.
EPS 1Y (TTM)22.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.54%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • TYME is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -7.64% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-88.44%
EPS Next 2Y-11.67%
EPS Next 3Y-7.64%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TYME Yearly Revenue VS EstimatesTYME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 200K 400K 600K 800K 1M
TYME Yearly EPS VS EstimatesTYME Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -0.1 -0.2 -0.3

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TYME. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TYME. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TYME Price Earnings VS Forward Price EarningsTYME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.02
TYME Per share dataTYME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

  • A cheap valuation may be justified as TYME's earnings are expected to decrease with -7.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.67%
EPS Next 3Y-7.64%

0

5. Dividend

5.1 Amount

  • No dividends for TYME!.
Industry RankSector Rank
Dividend Yield N/A

TYME TECHNOLOGIES INC / TYME FAQ

Can you provide the ChartMill fundamental rating for TYME TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to TYME.


Can you provide the valuation status for TYME TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 2 / 10 to TYME TECHNOLOGIES INC (TYME). This can be considered as Overvalued.


Can you provide the profitability details for TYME TECHNOLOGIES INC?

TYME TECHNOLOGIES INC (TYME) has a profitability rating of 2 / 10.


What is the financial health of TYME TECHNOLOGIES INC (TYME) stock?

The financial health rating of TYME TECHNOLOGIES INC (TYME) is 6 / 10.


What is the expected EPS growth for TYME TECHNOLOGIES INC (TYME) stock?

The Earnings per Share (EPS) of TYME TECHNOLOGIES INC (TYME) is expected to decline by -88.44% in the next year.